Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion type Assertion NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_head.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion evidence source_evidence_literature NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion SIO_000772 17558308 NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion wasDerivedFrom befree-20150227 NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion wasGeneratedBy ECO_0000203 NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.